Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies

Beijing Boren Hospital · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
acute lymphocytic leukemia, chronic lymphocytic leukemia, non hodgkin lymphoma, car-nk, cd19 positive, b-cell malignancy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832346
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.